junction with fibrosing alveolitis. In SSc comBackground -Systemic sclerosis (SSc) plicated by PHT the pulmonary vasculature may be complicated by pulmonary hyper-responsiveness to vasodilator medications is tension (PHT), which can occur both in often altered.
thesised that subjects with SSc and PHT radiologist and an assessment made of the presence or absence of a pattern consistent with may have decreased levels of exhaled NO. Exhaled NO was therefore measured in these fibrosing alveolitis. subjects and compared with levels in those with SSc without PHT and with normal individuals with no evidence of lung disease.
   Pulmonary function tests were performed at the same visit as measurement of exhaled NO. Forced expiratory flow volume curves were Methods  obtained using a dry rolling seal spirometer (PK Morgan Ltd, Gillingham, UK). T was Twenty three patients with a diagnosis of systemic sclerosis based on the preliminary criteria measured by a rebreathing manoeuvre using modified 19 transfer factor equipment (PK Morof the American Rheumatism Association 15 were studied. Patients were not considered for gan Ltd) and results amended to a 10 second single breath result. Arterialised capillary blood entry if there was evidence of any of the following conditions: (1) rheumatological overlap gases were taken 20 and analysed using a Corning 178 blood gas analyser (Ciba Corning, syndromes, (2) systemic hypertension, (3) airways disease, (4) respiratory tract infection, (5) Halstead, Essex, UK). Indices are expressed as percentage of predicted normal. 21 22 cardiac disease not related to SSc, or (6) if they were current smokers. Medication history was obtained from each patient with specific questions regarding the use of glucocorticosteroids      Peak exhaled NO was measured using a chemiand vasodilator medications. Patients with SSc and PHT were also compared with a group of luminescence analyser (Dasibi Environmental Corporation, Glendale, California, USA) spe-67 normal non-smoking individuals (40 men) of mean (SD) age 36 (7) years with no evidence cifically adapted for on-line recording of NO levels using a technique previously described. 23 of lung according to respiratory questionnaires and normal lung function (forced expiratory The sensitivity of the analyser ranged from 2 ppb to 4000 ppb by volume. Subjects pervolume in one second (FEV 1 ) 98 (2.4)% predicted). Although normal individuals were not formed a slow exhalation with flow rate of 500 ml/min from vital capacity over 30-45 secage or sex-matched, no relationship between sex, age, and exhaled NO has been reported, onds into wide bore Teflon tubing with NO being sampled continuously at a flow rate at least in adults. 16 17 250 ml/min. Three technically adequate recordings were made and an average of the peak values taken as the exhaled NO level. The     A non-invasive method of assessment of pul-coefficient of variation between the three exhalations used for subsequent analysis was 7%. monary pressure was considered to be more appropriate in this study. Pulmonary artery systolic pressure was estimated by Doppler echocardiography. M-mode and cross sectional   ANOVA test was used for comparisons between echocardiography (Hewlett Packard (Andover, Massachusetts, USA) was performed with the two groups. Linear regression analysis was used to assess the relationship between exhaled NO patient in the left lateral position. Non-imaging continuous wave Doppler signals were re-and the arterial oxygen tension (Pa 2 ) and multiple linear regression analysis was used corded with a Doptek (Southampton, UK) 2.0 MHZ transducer. Regurgitant flow was to assess whether the presence of PHT was independently related to exhaled NO (square identified in continuous wave mode at the apex. The peak instantaneous systolic pressure drop root transformation) using SPSS for Windows software. 24 from right ventricle to atrium was calculated from the peak signal velocity of the tricuspid regurgitant signal by the simplified Bernoulli equation. The final estimation of pulmonary Results Patients with SSc were characterised on the artery systolic pressure was obtained by adding the jugular venous pressure to the estimated basis of Doppler estimates of pulmonary artery systolic pressure (tables 1 and 2). The perpulmonary artery systolic pressure. PHT was diagnosed if pulmonary artery systolic pressure centage of patients with fibrosing alveolitis in each group was almost identical, and forced was estimated to be over 30 mmHg. Exclusion of PHT required both the demonstration of a vital capacity (FVC) measures suggested a similar physiological extent of fibrotic disease in the structurally normal right ventricle and a time interval between pulmonary valve closure and the start of tricuspid flow of less than 50 ms. All patients underwent thin section (3 mm)
Mean (SD) age (years) 36 (7) 50 (11) 61 ( Scans were analysed by an experienced thoracic group.bmj.com on July 7, 2017 -Published by http://thorax.bmj.com/ Downloaded from plicated by pulmonary hypertension there was a significant reduction in exhaled NO which was independent of age, sex, presence and two groups. Treatment that could potentially physiological extent of fibrosing alveolitis. affect exhaled NO (glucocorticoids or vasoMany cells residing within the respiratory dilator medications) was also similar in the two tract have the potential to release NO including disease groups (table 3). endothelial cells, neutrophils, 25 epithelial Exhaled NO was significantly lower in the cells, 26 and vascular smooth muscle cells. 27 patients with SSc and PHT (mean (SD) 20 However, the precise source of NO in exhaled (6) ppb) than in those with SSc without PHT air is unknown. NO is produced in high con-(149 (19) ppb, p<0.001; fig 1) . Exhaled NO centrations in the upper respiratory tract and was significantly higher in normal subjects (80 there has been concern that this may con-(7) ppb) than in patients with SSc and PHT taminate exhaled air. However, direct measure-(p<0.002) and significantly lower than in ment of NO via a bronchoscope has shown those with SSc without PHT (149 (19) ppb, that levels measured at the mouth reflect levels p<0.004), raising the possibility that either in the lower respiratory tract and that nasal endothelial cells or inflammatory cells in the contamination is not a problem providing NO lower respiratory tract in subjects with SSc may measurements are made during exhalation be producing increased amounts of NO. against a resistance causing soft palate There was no relationship between NO and closure. 28 29 Pa 2 in patients with SSc with PHT (r=0.04, In research and clinical trials the true pulp=0.94) but there was negative correlation monary artery pressure and right ventricular between these two parameters in patients with status relevant to prognosis and other tests of SSc without PHT (r=−0.49, p<0.05; fig 2) . function are considered to be shown by cardiac There was no relationship between exhaled NO catheterisation. However, a poorly prepared and T in patients with SSc either with patient may find catheterisation frightening and (r=0.2, p=0.71) or without (r=0.1, p=0.76) painful. Right heart pressures are normally so PHT. No correlation was found between ex-low that anxiety and alterations in breathing haled NO and pulmonary artery pressure (r= pattern and oxygenation may change them ap-−0.3, p=0.12).
preciably. A further difficulty is that catheterisation and non-invasive tests usually examine different aspects of the right ventricle (pressures, wall thickness, or cavity size) related to the general problem of cor pulmonale. Noninvasive tests are usually performed at rest and have, in general, been assessed for their ability to predict mean resting pulmonary artery pressure. Although the estimation of pulmonary hypertension using Doppler echocardiography is less accurate than pulmonary catheterisation, the non-invasive method of assessment of pulmonary pressure has been chosen as more appropriate in this study. We found exhaled NO to be significantly cells (macrophages and neutrophils) which are group.bmj.com on July 7, 2017 -Published by http://thorax.bmj.com/ Downloaded from frequently found in bronchoalveolar lavage in patients with pulmonary hypertension and hypoxia. 39 It is possible that patients with SSc fluid of patients with SSc and fibrosing alveolitis 30 and could release increased amounts of without PHT have pulmonary endothelial cells that are able to respond to mild hypoxia by NO.
Recently, little expression of inducible NOS increasing NO production, thus explaining the increased levels in exhaled breath. We speculate (iNOS) and nitrotyrosine has been shown in the airway epithelium in normal lungs. 31 In that patients with PHT have significant endothelial dysfunction and are unable to increase contrast, lungs of patients with early to intermediate pulmonary fibrosis showed abundant NO production.
There is substantial evidence that the endoexpression for both constitutive and inducible forms of NOS and peroxynitrite in the alveolar thelium is damaged early in the course of SSc.
Increased levels of von Willebrand's factor anepithelium and inflammatory cells. 31 Sustained high levels of NO, produced mainly by iNOS 12 tigen, considered indicative of endothelial injury, are found early in the course of the and mediated by nitrogen dioxide and/or peroxynitrite, may have severe pathological im-illness. 40 41 Studies examining skin in patients with SSc suggest that the initial vascular insult plications in pulmonary fibrosis. Oxidation of NO or decomposition of peroxynitrite produces is focused on the endothelial cell [4] [5] [6] and that vascular damage occurs before other pathothe reactive free radicals which have been shown in the rat to cause pulmonary par-logical changes such as fibrosis. Data regarding the pulmonary endothelial cell in SSc are limenchymal and vascular alterations similar to those seen in pulmonary fibrosis. [32] [33] [34] ited. However, increased albumin levels have been found in bronchoalveolar lavage fluid in Although the mechanism underlying the development of PHT in systemic sclerosis is com-patients without fibrosing alveolitis, suggesting that abnormal endothelial permeability occurs plex and unknown, there is some evidence that NO may play a part in the development of early in the disease. 42 The mechanism of endothelial damage in SSc is unclear, but un-PHT or simply reflect the loss of a vascular bed. Thus, there was almost no iNOS expression in identified circulating substances present in serum from patients with SSc have the potential alveolar epithelium and inflammatory cells in patients with end-stage pulmonary fibrosis and to cause morphological changes to endothelial cells in culture, and could potentially be inpulmonary hypertension. 31 Indeed, exhaled NO levels were significantly decreased in volved in mediating endothelial damage. [43] [44] [45] There are several ways in which diminished patients with SSc and PHT compared with patients without PHT.
endothelial cell production of NO could be involved in the development of PHT in patients The presence of raised pulmonary artery pressure in the pulmonary hypertensive group with SSc. Diminished production of this endogenous vasodilator could lead to the unopposed also implies a comparatively greater degree of structural damage to the pulmonary arterial action of vasoconstrictor substances such as endothelin-1 (ET-1), increasing pulmonary tree with a smaller number of endothelial cells available to release NO into expired air. Endo-vascular resistance. Additionally, impairment of NO release could augment endothelial exthelial dysfunction in the pulmonary hypertensive patients may therefore be an additional pression of ET-1.
46 NO deficiency may not only cause vasoconstriction but may lead to cause of the low exhaled NO levels observed in this group. Indeed, T was significantly obstructive and proliferative changes in pulmonary arteries. reduced in the group with PHT, suggesting a reduction in effective capillary blood volume.
NO is known to be an inhibitor of platelet adhesion to vascular endothelium. [47] [48] [49] ImpairThe reduction in NO release could be simply a consequence of the pulmonary hypertension. ment of NO release could therefore encourage in situ thrombosis, worsening vascular narrowing However, considering the role of NO in pulmonary circulatory regulation and the fact that caused by vasoconstriction, 50 and increase monocyte migration into the vascular wall, 51 52 en-NO is a powerful endogenous and exogenous vasodilator, the existence of a complex couraging fibrointimal proliferation. 53 54 Pulmonary hypertension may be difficult to pathogenesis of pulmonary hypertension development and the role of NO as a causative diagnose, especially at an early stage. In SSc a decrease in T is recognised as a risk factor agent cannot be excluded. Moreover, the reduction in NO release might be a useful marker for development of PHT.
2 Depression of T is, however, relatively common in SSc and of the presence of pulmonary hypertension rather than a marker of a propensity for pul-reflects the loss of effective capillary blood flow. 55 A test that identified patients with SSc monary hypertension.
The effect of hypoxia on NO production is at significantly increased risk for the development of PHT would be valuable as it is controversial. Although the negative correlation between exhaled NO and Pa 2 in likely that any intervention that could alter the natural history of this condition would need to patients with PHT may simply reflect the presence of worse systemic sclerosis, the loss of be initiated before there were marked structural changes in the pulmonary vessels. We have endothelially mediated vasodilatation in conditions associated with chronic hypoxia 35 36 has found significantly decreased levels of exhaled NO in subjects with SSc and PHT compared been demonstrated, suggesting deficient production of NO. Alternatively, an increase in with both those with SSc without PHT and normal individuals. Though the cellular origin pulmonary artery pressure has been shown when NO synthesis is inhibited, 37 38 suggesting of exhaled NO is not known, these results are consistent with the concept that in patients with a possible protective vasodilatory role for NO 
